Osimertinib for Lung Squamous Cell Carcinoma: A Case Report and Literature Review

The efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in lung squamous cell carcinoma is said to be low. Thus far, only four cases of osimertinib in lung squamous cell carcinoma have been published. We experienced a case of EGFR mutant lung squamous cell carcinoma i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimatsu, Yuki, Ebi, Noriyuki, Ooi, Ryunosuke, Sueyasu, Takuto, Nishizawa, Saori, Munechika, Miyuki, Yoshimine, Kohei, Ko, Yuki, Ide, Hiromi, Tsuruno, Kosuke, Tobino, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079920/
https://www.ncbi.nlm.nih.gov/pubmed/33132329
http://dx.doi.org/10.2169/internalmedicine.5463-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079920/
https://www.ncbi.nlm.nih.gov/pubmed/33132329
http://dx.doi.org/10.2169/internalmedicine.5463-20

Ejemplares similares